Corbion N.V. — Capital/Financing Update 2015

Dec 30, 2015

PRESS RELEASE

CORPORATE RELEASE

Corbion nv Piet Heinkade 127 • 1019 GM Amsterdam PO Box 349 • 1000 AH Amsterdam The Netherlands

T +31 (0)20 590 6911 Press@corbion.com www.corbion.com

DATE 30 December 2015

Corbion signed USD 125 million US Private Placement Notes

Corbion has signed a US Private Placement (USPP) Notes program with 4 institutional investors. The issuance of USD 125 million under this program consists of one tranche with a maturity of 10 years and a fixed interest rate of 4.17%.

Part of the proceeds will be used to replace USD 85 million from the 2010 USPP that matured in October 2015. Of the 2010 USPP, USD 42 million will still be outstanding.

Combined with the available Revolving Credit Facilities, this program will give us the necessary flexibility in our funding needs to execute our investment plans in the coming years.

For more information, please contact:

Jeroen van Harten, Director Investor Relations

T +31 (0)20 5906293, M +31(0)6 21 577 086

Background information:

Corbion: biobased solutions, designed by science, powered by nature, and delivered through dedication.

Corbion is the global market leader in lactic acid, lactic acid derivatives and lactides, and a leading company in emulsifiers, functional enzyme blends, minerals and vitamins. The company delivers high performance biobased products made from renewable resources and applied in global markets such as bakery, meat, pharmaceuticals and medical devices, home and personal care, packaging, automotive, coatings and adhesives. Its products have a differentiating functionality in all kinds of consumer products worldwide. In 2014, Corbion generated annual sales of €770.1 million and had a workforce of 1,893 employees. Corbion is listed on NYSE Euronext Amsterdam. For more information: www.corbion.com